Overall survival rate for children with cancer approximately 80%

Cancer, Children's Health
The Wall Street Journal "Health Blog" reported that research published online in the Journal of Clinical Oncology indicates that the overall survival rate for children with cancer is now approximately 80%. This is GREAT news. However, during the past 10-20 years, the five-year survival rates for most solid tumors in children and teenagers have not changed, but overall, we're curing more childhood cancer than we ever have in the past. Nevertheless, with many newer and more effective treatments available for kids, the researchers report that "when 1975 age-specific death rates for children are used as a baseline, approximately 38,000 childhood malignant cancer deaths were averted in the United States from 1975 through 2006 as a result of more effective treatments identified and applied during this period." The blog also included…
Read More

Calcium and multivitamins may be linked to reduced breast cancer risk

General Health
Daily Calcium Plus Vitamin D Supplements May Reduce Fracture RiskBloomberg News reports that "calcium doesn't just build strong bones, it may fight cancer too," according to a study presented at the meeting of the American Association for Cancer Research. Investigators found "that women who took calcium had a 40% lower risk of getting breast cancer, while those getting multivitamins showed a 30% reduction in risk." These "data contradict results of a December 2008 trial that showed no reduction in cancer risk from vitamin supplements." HealthDay pointed out that "the authors of the study ... did not separate out which specific vitamins might be beneficial, but suggested that the interactions of different vitamins together might account for the beneficial effect." You can read a couple of my other posts about the benefits of…
Read More

Hormone Therapy for Menopause Reviewed

Woman's Health
According to a new review of the role of perimenopausal hormone therapy published in Obstetrics & Gynecology, women must be informed of the potential benefits and risks of all treatment options for menopausal symptoms and concerns and should receive individualized care. Here's an update from MedPage. It's long, but very helpful: "With the first publication of the results of the Women's Health Initiative (WHI) trial in 2002, the use of HT [hormone therapy] declined dramatically," write Jan L. Shifren, MD, and Isaac Schiff, MD, from Harvard Medical School and Massachusetts General Hospital in Boston. "Major health concerns of menopausal women include vasomotor symptoms, urogenital atrophy, osteoporosis, cardiovascular disease, cancer, cognition, and mood. ... Given recent findings, specifically regarding the effect of the timing of HT initiation on coronary heart disease…
Read More